Skip to content
Lebsa EN
  • WHO WE ARE
    • Who we are
      • Our team
      • Facilities
      • GMP Pilot Plant
      • Why us
      • Where we are
  • API’s
    • Standard API’s
      • Amisulpride
      • Betahistine Dihydrochloride
      • Betahistine Dimesilate
      • Bromopride
      • Dequalinium Chloride
      • Dibrompropamidine Isetionate
      • Histamine Dihydrochloride
      • Histamine Diphosphate Monohydrate
      • Lacidipine
      • Mianserin Hydrochloride
      • Picloxidine Dihydrochloride
      • Propamidine Isetionate
      • Sulpiride
      • Tiapride Hydrochloride
      • Venetoclax
      • Octenidine Dihydrochloride
    • API’s Pipeline
      • Letermovir
  • CUSTOMER SUPPORT
    • Customer Support
      • Beyond Quality
      • Regulatory support
      • Sustainability
      • API CDMO Services
  • API R&D
    • API R&D
      • Flow chemistry
      • GMP Pilot Plant
  • BLOG
  • CONTACT
  • ENG
    • English
    • Español
Login

Category: News

Categories

  • News & Events
  • Innovation
  • R&D
  • Quality
  • Values
  • Sustainability
  • APIs
LEBSA lidera junto a Leitat el proyecto PHARO

LEBSA, together with Leitat, leads the PHARO project, a pioneering circular economy initiative in the pharmaceutical industry based on water regeneration

The project aims to optimize the production processes of the industry and focuses on (…)

Read more

Moments to Remember: LEBSA’s Heartwarming Christmas Dinner 2023

Celebrating unforgettable moments at LEBSA! This year, we immersed ourselves in the holiday spirit (…)

Read more

Lebsa shareholders meeting: tradition and innovation unite to take the company to new heights

Reliving strategic moment from the latest Lebsa Board of shareholders meeting! In late October, (…)

Read more

Lebsa equipo

Lebsa and Selectchemie Join Forces at CPHI Barcelona to Drive Innovation in the Pharmaceutical Industry

At the recent internationally renowned event, CPHI Barcelona, the pharmaceutical industry gathered at Fira (…)

Read more

conference

What Is Coming Next?

After two years of pandemic, this 2022, events and congresses are back and at (…)

Read more

Mluisa Speach

Presenting “Entenent LEBSA”: our origins, values and philosophy

On Friday, 29th of April, during the commemorative event for Lebsa’s 70th anniversary, the (…)

Read more

CEP Mianserin Hydrochloride

EDQM grants the CEP to Mianserin Hydrochloride API

One of the critical values of Lebsa is to provide regulatory support and keep (…)

Read more

70 years Lebsa

Lebsa celebrates 70 years

Since Dr. Josep Maria Espinós founded Lebsa in 1951, we have served the pharmaceutical (…)

Read more

mianserin

Mianserin in the treatment of depression and insomnia

The public health emergency triggered by COVID-19 is not only a matter of respiratory (…)

Read more

LEBSA, your partner in API’s Manufacturing in Barcelona (EU)

CONTACT US
  • Your Partner in API’s Manufacturing
  • Who we are

    • Our Team
    • Facilities
    • GMP Pilot Plant
    • Why Us
    • Where We Are
  • Connect

    Follow us

  • Youtube

  • Legal Notice
  • Standard API’s

    • Amisulpride
    • Betahistine Dihydrochloride
    • Betahistine Dimesilate
    • Bromopride
    • Dequalinium Chloride
    • Dibrompropamidine Isetionate
    • Histamine Diphosphate Monohydrate
    • Histamine Dihydrochloride
    • Lacidipine
    • Picloxidine Dihydrochloride
    • Propamidine Isetionate
    • Sulpiride
    • Tiapride Hydrochloride
    • Mianserin Hydrochloride
    • Venetoclax
    • Octenidine Dihydrochloride
  • API’s Pipeline

    • Letermovir
  • Customer Support

    • Beyond Quality
    • Regulatory Support
    • Sustainability
  • API R&D

    • Flow chemistry
    • GMP Pilot Plant
  • Contact Info

    34 93 377 00 51

    lebsa@lebsa.com

    Ctra. de l’Hospitalet, 34
    08940 Cornellà (Barcelona)

  • AENOR certificate ISO 9001
  • AENOR certificate ISO 14001
  • AENOR Certificate ISO 45001
  • Quality System IQNet
2025 LEBSA All rights reserved. Website Powered by tbbAgency